Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: the open-label Study 342 (FREEDOM Study) (vol 5, pg 274, 2020)

被引：0
|
作者：
Yamamoto
机构：
来源：
EPILEPSIA OPEN | 2020年 / 5卷 / 03期
关键词：
D O I：
10.1002/epi4.12416
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：518 / 518
页数：1
相关论文
共 43 条
  • [21] Efficacy and safety of perampanel monotherapy in Chinese patients with focal-onset seizures: A single-center, prospective, real-world observational study
    Ma, Haiyan
    Zhu, Haitao
    Chen, Fangqing
    Yang, Yiqing
    Qu, Xuefeng
    Xu, Honghao
    Yang, Lu
    Zhang, Rui
    EPILEPSIA OPEN, 2023, 8 (04) : 1474 - 1483
  • [22] Efficacy and Safety of Perampanel Monotherapy in Patients with Newly Diagnosed or Currently Untreated Recurrent Partial-Onset Seizures (POS): Final Analysis of Study 342 (FREEDOM) 4 and 8 mg/day Core Data
    Yamamoto, Takamichi
    Kim, Ji Hyun
    Lim, Sung Chul
    Ninomiya, Hirotomo
    Kubota, Yuichi
    Matsunaga, Risa
    Hiramatsu, Hidetaka
    NEUROLOGY, 2020, 94 (15)
  • [23] THE KOMET STUDY: AN OPEN-LABEL, RANDOMIZED, PARALLEL-GROUP TRIAL COMPARING THE EFFICACY AND SAFETY OF LEVETIRACETAM WITH SODIUM VALPROATE AND CARBAMAZEPINE AS MONOTHERAPY IN SUBJECTS WITH NEWLY DIAGNOSED EPILEPSY
    Pohlmann-Eden, Bernd
    Van Paesschen, Wim
    Hallstrom, Y.
    Marson, A.
    Kalviainen, R.
    Marovac, J.
    Buyle, S.
    Edrich, P.
    Trinka, Eugen
    EPILEPSIA, 2008, 49 : 448 - 449
  • [24] THE KOMET STUDY: AN OPEN-LABEL, RANDOMIZED, PARALLEL-GROUP TRIAL COMPARING THE EFFICACY AND SAFETY OF LEVETIRACETAM WITH SODIUM VALPROATE AND CARBAMAZEPINE AS MONOTHERAPY IN SUBJECTS WITH NEWLY DIAGNOSED EPILEPSY
    Trinka, E.
    Van Paesschen, W.
    Hallstrom, Y.
    Hon, P.
    Marson, A.
    Muscas, G.
    Kalviainen, R.
    Buyle, S.
    Marovac, J.
    Edrich, P.
    Pohlmann-Eden, B.
    EPILEPSIA, 2009, 50 : 45 - 45
  • [25] Efficacy and Safety of adjunctive Perampanel in a prospective, real-world, Phase IV study in Indian patients aged ≥12 years for Treatment of focal-onset Epilepsy: Study 508
    Ravat, Sangeeta
    Rohatgi, Anshu
    Kulkarni, Rahul
    Jabeen, Shaik A.
    Patil, Balaji
    Dash, Amitabh
    Malhotra, Manoj
    EPILEPSIA OPEN, 2024, 9 (03) : 940 - 950
  • [26] Long-term efficacy and safety of lamotrigine monotherapy in Japanese and South Korean pediatric patients with newly diagnosed typical absence seizures: An open-label extension study
    Yasumoto, Sawa
    Ohtsuka, Yoko
    Sato, Katsuaki
    Kurata, Atsuyo
    Numachi, Yotaro
    Shimizu, Masahiro
    BRAIN & DEVELOPMENT, 2018, 40 (09): : 786 - 791
  • [27] Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese patients with epilepsy
    Usui, Naotaka
    Akamatsu, Naoki
    Nakasato, Nobukazu
    Ohnishi, Akihiro
    Kaneko, Sunao
    Hiramatsu, Hidetaka
    Saeki, Kazunori
    Miyagishi, Hideaki
    Inoue, Yushi
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 62 : 26 - 32
  • [28] Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures
    Fogarasi, Andras
    Flamini, Robert
    Milh, Mathieu
    Phillips, Steven
    Yoshitomi, Shinsaku
    Patten, Anna
    Takase, Takao
    Laurenza, Antonio
    Ngo, Leock Y.
    EPILEPSIA, 2020, 61 (01) : 125 - 137
  • [29] Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal-onset seizures: Post-hoc analysis from a phase III, randomized, double-blind study and a 2-year open-label extension ESL study
    Trinka, Eugen
    Rocamora, Rodrigo
    Moreira, Joana
    Pereira, Ana
    Fonseca, Miguel
    Fernandez, Guillermo Castilla
    Ikedo, Fabio
    NEUROLOGY, 2021, 96 (15)
  • [30] Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study
    Abou-Khalil, Bassel
    Aboumatar, Sami
    Klein, Pavel
    Krauss, Gregory L.
    Sperling, Michael R.
    Rosenfeld, William E.
    EPILEPSY RESEARCH, 2022, 184
12345